The Role of H3.3 histone variant in the pathogenesis of oral Kaposi's Sarcoma

H3.3组蛋白变异在口腔卡波西肉瘤发病机制中的作用

基本信息

  • 批准号:
    10418661
  • 负责人:
  • 金额:
    $ 35.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-09-04 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Abstract Kaposi's sarcoma-associated herpesvirus (KSHV) is the etiological agent of Kaposi's sarcoma (KS), and two lymphoproliferative diseases: primary effusion lymphoma (PEL) and multicentric Castleman's disease (MCD). KS is the most common oral cancer in human immunodeficiency virus (HIV)-infected patients. The oral cavity is the major site for virus transmission via saliva. Although the incidence of AIDS-KS cases has been reduced in the US due to combination antiretroviral therapy (cART), recent studies suggest recurrence of oral KS in long-term treated AIDS patients. While KS tumor cells are mostly latently infected, and express a limited number of viral genes, gingival epithelial cells in the oral cavity actively replicate KSHV which is important for a) seeding the latency reservoir in B cells after primary infection and b) shedding in the oral cavity and transmission via saliva. Epigenetics and chromatin structure play a central role in the regulation of both transcription and replication. Deregulation, aberrant deposition, and mutations of histone variants such as H3.3, CENP-A, and H2A.Z and their associated chaperones have been implicated in multiple human cancers including head and neck. After de novo infection, KSHV genomes rapidly associate with nucleosomes which acquire specific epigenetic modifications that partition the viral episome into transcriptionally active and silenced domains. While multiple KSHV epigenetic marks have been mapped in lymphoid, epithelial and endothelial cells, the processes and potential host- viral interactions leading to the formation of latency permissive episomes are still poorly understood. Given that the KSHV latency-associated nuclear antigen (LANA) interacts with both chromatin remodelers and H3.3 histone chaperones Daxx, HIRA, and DEK, we hypothesize that H3.3 deposition plays an important role in the establishment and maintenance of KSHV latency. Our preliminary data demonstrate that H3.3 deposition on KSHV episomes can be detected early after de novo infection on episomes of long-term infected cells. Moreover, we demonstrated that genetically disrupting the H3.3 chaperone pathways HIRA and Daxx by CRISPR/Cas9 leads to marked changes in KSHV latency control, associated with alterations in the epigenetic status. We further hypothesize that latency-associated gene products including LANA modulate and or de-regulate histone chaperone pathways during de novo infection and latency. To directly address this hypothesis we propose to mechanistically study histone H3.3 deposition and the formation of histone post translational modifications (PTMs), with the goal of understanding their relationship with respect to viral gene expression and latent/lytic replication. A main aspect of these studies is to investigate how viral gene products interact with and modulate histone variant chaperone pathways. In addition, we use human oral primary epithelial cells which are more lytic than transformed epithelial cell lines to characterize epigenetic changes responsible for their lytic phenotype. Importantly, through a collaboration with Dr. Donald Cohen, College of Dentistry, we propose to establish in vivo epigenomes of oral KS in both formalin-fixed and snap frozen tumor samples. The overall goal is to investigate how histone variant deposition determines latent and lytic infection in a cell type-specific manner. The results may point to KSHV-specific novel therapeutic targets for oral KS.
摘要

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Coordination of transcription, processing, and export of highly expressed RNAs by distinct biomolecular condensates.
  • DOI:
    10.1042/etls20190160
  • 发表时间:
    2020-12-11
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    Ishov AM;Gurumurthy A;Bungert J
  • 通讯作者:
    Bungert J
Inhibition of Mps1 kinase enhances taxanes efficacy in castration resistant prostate cancer.
MPS1激酶的抑制作用增强了抗castratiation抗性前列腺癌中紫杉烷的功效。
  • DOI:
    10.1038/s41419-022-05312-8
  • 发表时间:
    2022-10-13
  • 期刊:
  • 影响因子:
    9
  • 作者:
    Sarwar, Sadia;Morozov, Viacheslav M.;Purayil, Hamsa;Daaka, Yehia;Ishov, Alexander M.
  • 通讯作者:
    Ishov, Alexander M.
Sex-biased expression is associated with chromatin state in D. melanogaster and D. simulans.
性别偏向表达与黑腹果蝇和拟果蝇中的染色质状态相关。
  • DOI:
    10.1101/2023.01.13.523946
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Nanni,AdalenaV;Martinez,Natalie;Graze,Rita;Morse,Alison;Newman,JeremyRB;Jain,Vaibhav;Vlaho,Srna;Signor,Sarah;Nuzhdin,SergeyV;Renne,Rolf;McIntyre,LaurenM
  • 通讯作者:
    McIntyre,LaurenM
Super-enhancer mediated regulation of adult β-globin gene expression: the role of eRNA and Integrator.
  • DOI:
    10.1093/nar/gkab002
  • 发表时间:
    2021-02-22
  • 期刊:
  • 影响因子:
    14.9
  • 作者:
    Gurumurthy A;Yu DT;Stees JR;Chamales P;Gavrilova E;Wassel P;Li L;Stribling D;Chen J;Brackett M;Ishov AM;Xie M;Bungert J
  • 通讯作者:
    Bungert J
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ROLF F RENNE其他文献

ROLF F RENNE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ROLF F RENNE', 18)}}的其他基金

Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
γ-疱疹病毒生物学和艾滋病恶性肿瘤中的非编码 RNA
  • 批准号:
    10812041
  • 财政年份:
    2023
  • 资助金额:
    $ 35.53万
  • 项目类别:
"Project 1" KSHV short and long noncoding RNAs and alteration of host IncRNA expression
“项目 1”KSHV 短非编码 RNA 和长非编码 RNA 以及宿主 IncRNA 表达的改变
  • 批准号:
    10865781
  • 财政年份:
    2023
  • 资助金额:
    $ 35.53万
  • 项目类别:
"Project 1" KSHV short and long noncoding RNAs and alteration of host IncRNA expression
“项目 1”KSHV 短非编码 RNA 和长非编码 RNA 以及宿主 IncRNA 表达的改变
  • 批准号:
    10403015
  • 财政年份:
    2017
  • 资助金额:
    $ 35.53万
  • 项目类别:
"Project 1" KSHV short and long noncoding RNAs and alteration of host IncRNA expression
“项目 1”KSHV 短非编码 RNA 和长非编码 RNA 以及宿主 IncRNA 表达的改变
  • 批准号:
    10646225
  • 财政年份:
    2017
  • 资助金额:
    $ 35.53万
  • 项目类别:
"Core A" Administrative Core
“核心A”行政核心
  • 批准号:
    10646248
  • 财政年份:
    2017
  • 资助金额:
    $ 35.53万
  • 项目类别:
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
γ-疱疹病毒生物学和艾滋病恶性肿瘤中的非编码 RNA
  • 批准号:
    10646224
  • 财政年份:
    2017
  • 资助金额:
    $ 35.53万
  • 项目类别:
"Core A" Administrative Core
“核心A”行政核心
  • 批准号:
    10403018
  • 财政年份:
    2017
  • 资助金额:
    $ 35.53万
  • 项目类别:
"Core C" Recombinant Virus Core
“Core C”重组病毒核心
  • 批准号:
    10646256
  • 财政年份:
    2017
  • 资助金额:
    $ 35.53万
  • 项目类别:
"Core C" Recombinant Virus Core
“Core C”重组病毒核心
  • 批准号:
    10403020
  • 财政年份:
    2017
  • 资助金额:
    $ 35.53万
  • 项目类别:
Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies
γ-疱疹病毒生物学和艾滋病恶性肿瘤中的非编码 RNA
  • 批准号:
    10818838
  • 财政年份:
    2017
  • 资助金额:
    $ 35.53万
  • 项目类别:

相似海外基金

Molecular pathological mechanisms of the brain development disorder using the chromatin-remodeling molecule ATRX gene knockout mouse
染色质重塑分子ATRX基因敲除小鼠脑发育障碍的分子病理机制
  • 批准号:
    23300147
  • 财政年份:
    2011
  • 资助金额:
    $ 35.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Functional analysis of the Zn finger domain encoded by the ATRX gene whose mutations result in X-linked alpha thalassemia mental retardation(ATR-X) syndrome
ATRX基因编码的锌指结构域的功能分析,其突变导致X连锁α地中海贫血精神发育迟滞(ATR-X)综合征
  • 批准号:
    18570170
  • 财政年份:
    2006
  • 资助金额:
    $ 35.53万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A Y CHROMOSOME MODEL FOR THE SEX DETERMINING FUNCTION OF THE HUMAN ATRX GENE
人类 ATRX 基因性别决定功能的 Y 染色体模型
  • 批准号:
    nhmrc : 148630
  • 财政年份:
    2001
  • 资助金额:
    $ 35.53万
  • 项目类别:
    NHMRC Project Grants
Investigation of the role of the ATRX gene in normal mammalian development
ATRX 基因在正常哺乳动物发育中的作用研究
  • 批准号:
    nhmrc : 987013
  • 财政年份:
    1998
  • 资助金额:
    $ 35.53万
  • 项目类别:
    Early Career Fellowships
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了